Navigation Links
Prescription-Drug Plans' Use of Specialty Tiers Promotes Inequalities
Date:8/10/2011

WASHINGTON, Aug. 10, 2011 /PRNewswire-USNewswire/ -- In a just-released National Minority Quality Forum Issue Brief (Specialty Tiering: Unequal Treatment http://www.nmqf.org/IB3SpecialtyTiersFinal.pdf), Gary Puckrein and Gretchen Wartman examine specialty tiering, which has become popular among insurers (public and private) as a benefit-management tool to limit their financial exposure by requiring beneficiaries to pay more for certain high-cost prescription drugs. The authors remind us that, the Institute of Medicine cautioned in 2003: "Aspects of health systems—such as the ways in which systems are organized and financed, and the availability of services—may exert different effects on patient care, particularly for racial and ethnic minorities" (Brian D. Smedley, Adrienne Y. Stith, and Alan R. Nelson, eds., Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care [Washington, DC: National Academies Press, 2003], p. 8). Specialty tiering exerts different effects by design. It chips away at the risk-pooling effects of insurance by shifting a significant percentage of the cost of expensive medical treatments to beneficiaries, possibly forcing the less affluent to choose between paying for basic living expenses or taking their medications. Cost shifting without means testing compromises access to quality care and increases the potential for disparate and poor health-care outcomes among minority populations, the financially less able, beneficiaries with cancer or other complex diseases that require expensive medical therapies, and those whose biologies may cause them to metabolize drugs differently.

"We believe that this issue brief is quite timely," explains Dr. Puckrein, who is president and chief executive officer of the National Minority Quality Forum. "The current economy not only calls for creativity and a willingness to find new answers for old problems, but also necessitates a steadfast commitment to the principle that the health and safety of all Americans is paramount. The temptation to quietly erect barriers to quality health care through specialty tiers and other forms of cost shifting that are insensitive to a beneficiary's financial abilities must be resisted. Cost shifting will be dressed up as an easy and obvious solution, but insurers should have no role in picking winners and losers among those who depend upon them."

The issue brief explores the important contribution that health insurance (public as well as private) has made to improvements in the quality of life and to longevity in this country. In this context, Dr. Puckrein and Ms. Wartman question the wisdom of specialty tiering and urge insurers to stop the practice.

About the National Minority Quality Forum
Founded as a nonprofit organization in 1998, the National Minority Quality Forum (http://www.nmqf.org) was established to strengthen national and local efforts to eliminate the disproportionate burden of premature death and preventable illness in racial and ethnic minorities and other special populations through the use of evidence-based, data-driven initiatives.


'/>"/>
SOURCE National Minority Quality Forum
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. PCMA: Part D Plans and PBMs Continue to Deliver Savings in Medicare
2. Cardium Provides Update on Excellagen 510(K) Registration and Commercialization Plans
3. McNeil Consumer Healthcare Announces Plans for New Dosing Instructions for TYLENOL® Products
4. OM Group Announces Retirement Plans of Chief Financial Officer Kenneth Haber
5. Cardium Announces Plans to Acquire Transdel Pharmaceuticals Phase 3 Topical Analgesic and Cosmeceutical Business Assets
6. Vertex Plans to Provide Access to Potential CF Therapy VX-770 for Patients with Critical Medical Need
7. InterMune to Provide Overview of Corporate Strategy, Update on Esbriet Commercialization Plans in the EU and Details of Phase 3 ASCEND Study
8. Dendreon Announces Clinical Trial Plans for PROVENGE and DN24-02 at the American Society of Clinical Oncology Annual Meeting
9. Polaris Group to Highlight Clinical Development Plans for Phase 3-Ready Candidate, ADI-PEG 20, During Symposium in Taiwan
10. KemPharm, Inc. Announces Plans to Launch KP106 as First Oral Film Dosage Form for ADHD
11. Amgen Outlines Strategy, Growth Objectives and Capital Allocation Plans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... , May 24, 2016 ... the world , s first dual therapy ... intervention   OrbusNeich, a global company specializing ... its portfolio to include products to treat peripheral artery ... company,s first entry devices for lower limb and arteriovenous ...
(Date:5/24/2016)... -- Open Access Journal Focusing on ... Elsevier , a world-leading provider of scientific, technical ... launch of Clinical Neurophysiology Practice ... clinical practice issues in clinical neurophysiology. The journal will ... and didactic reviews. It is an official journal of ...
(Date:5/23/2016)... According to a new ... Product (Wheelchair, Scooters, Medical Beds, Bathroom Safety, Mechanical, ... Wound), Accessories (Lifting, Transfer) & by End User ... MarketsandMarkets, the patient handling equipment market is expected ... a CAGR of 10.5% during the forecast period ...
Breaking Medicine Technology:
(Date:5/25/2016)... ... May 25, 2016 , ... ... a Managing Partner at HealthScape Advisors. “Brad brings significant experience advising healthcare provider ... delivery system accelerates with the implementation of MACRA, we believe that continuing to ...
(Date:5/25/2016)... ... May 25, 2016 , ... A new update to Xsens popular ... by utilizing a common Wi-Fi network and a mobile device. When paired with Xsens ... with Wi-Fi, and use a mobile device to control the recording. , “The ...
(Date:5/25/2016)... ... 25, 2016 , ... There was a time when tampons and pads were the only options ... turning to menstrual cups, like Lunette . To make that time of the month ... in this catchy video ! , It’s easy to see why Lunette is ...
(Date:5/25/2016)... ... May 25, 2016 , ... Dr. Travis Schwarz is an experienced ... Mexico Road, O’Fallon, MO 63366. He serves patients of all ages with a full ... Dr. Schwarz’s success is reflected in the superior patient reviews that he has consistently ...
(Date:5/25/2016)... ... May 25, 2016 , ... ... and products in the developing world, is pleased to release their 2015 global ... 5 million unwanted pregnancies, almost 14,000 maternal deaths and 3.8 million unsafe abortions ...
Breaking Medicine News(10 mins):